Abstract

Antigen recognition by cytotoxic T lymphocytes (CTLs) is mediated via cell surface molecules (1,2). These involve the T3 molecular complex and the T4, T8, and T11 antigens. Phorbol esters induce a variety of phenotypic changes in lymphocytes, e.g., increased expression of the receptor for interleukin-2 (IL-2) and temporary down-modulation of the T3 receptor complex (3). These phenotypic changes are paralleled by an increased sensitivity to IL-2 and a temporary unresponsiveness to antigen (3). To further characterize the functional changes which accompany the alterations in phenotype we monitored the phorbol ester-induced antigenic changes of cytotoxic T cells defined by monoclonal antibodies to the T11, T8, and T3 molecules and correlated them with the functional changes which occur after phorbol ester stimulation. It was found that after treatment with this most potent tumor promoter—phorbol ester, 12-O-tetra-decanoylphorbol-13-acetate (TPA)—the amount of T3, T4, and T8 molecules decreased on the cell surface while T11 increased. These phenotypic changes are paralleled by temporary loss of cytotoxic activity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.